# SodiUm SeleniTe Adminstration IN Cardiac Surgery (SUSTAIN CSX®-Trial).

> **NCT02002247** · PHASE3 · UNKNOWN · sponsor: **Daren K. Heyland** · enrollment: 1400 (estimated)

## Conditions studied

- Heart Disease

## Interventions

- **DRUG:** sodium selenite
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02002247
- **Lead sponsor:** Daren K. Heyland
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-01
- **Primary completion:** 2021-02
- **Final completion:** 2021-07
- **Target enrollment:** 1400 (ESTIMATED)
- **Last updated:** 2021-06-01

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02002247

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02002247, "SodiUm SeleniTe Adminstration IN Cardiac Surgery (SUSTAIN CSX®-Trial).". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02002247. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*